Venous thrmoboembolism
Conditions
Interventions
Application of the patient pathway as recommended in the Dutch guideline
Sponsors
LUMC
Eligibility
Inclusion criteria
Inclusion criteria: All patients with PCR proven COVID-19 diagnosed with VTE in the participating centers, who has survived the initial 3-month follow-up
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Establish the rate of thrombus resolution and the incidence of post-VTE syndromes in COVID-19 survivors diagnosed with and treaded for VTE, in the perspective of historical Dutch VTE controls from the pre-COVID-19 era. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Evaluate the incidence of COVID-19 associated VTE after hospital discharge - Assess patient reported outcome measures and pulmonary and cardiac function in the perspective of historical Dutch VTE controls from the pre-COVID-19 era and COVID-19 survivors who were not diagnosed with VTE | — |
Contacts
Public ContactErik Klok
LUMC
Outcome results
None listed